Can a tailored antibiotic regimen shorten endocarditis treatment without risk?
NCT ID NCT03851575
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial investigates whether a shorter course of antibiotics, tailored to each patient's response, can safely treat bacterial endocarditis. Standard treatment lasts 4-6 weeks, but this study tests a personalized approach based on factors like fever and blood tests. The goal is to reduce hospital stays and associated risks while maintaining effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a personalized, shortened course of intravenous antibiotics
- What this could lead to
- If successful, this could shorten hospital stays and reduce risks like mental strain and loss of function for patients with endocarditis.
- What could go wrong
- This is a single-center trial, and the shorter course may not be as effective as standard treatment, potentially increasing the risk of complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS ENDOCARDITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bispebjerg Hospital
Copenhagen, Denmark
-
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
-
Gødstrup Regional Hospital
Gødstrup, Denmark
-
Herlev Hoslpital
Copenhagen, Denmark
-
Hillerød Hospital
Hillerød, Denmark
-
Hvidovre Hospital
Hvidovre, Denmark
-
Odense Sygehus
Odense, 5000, Denmark
-
Rigshospitalet
Copenhagen, Denmark, 2100, Denmark
-
Roskilde Sygehus, Zealand University hospital
Roskilde, Denmark
-
Skejby Sygehus
Aarhus, 8200, Denmark
-
Skåne University Hospital
Lund, Sweden
-
Vejle Hospital
Vejle, Denmark
-
Viborg Hospital
Viborg, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.